Form 4 for TXN Texas Instruments
Accepted 2022-01-31 00:00:00 ET · period of report 2021-09-08 · accession 0001127602-22-002634 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-31 | 2022-01-31 | TXN | Lizardi Rafael R | CFO, Sr. VP | F - Tax | $177.29 | -3,658 | 54.9K | -6% | -$648.5K |
| DMI | 2022-01-31 | 2021-09-08+ | TXN | Lizardi Rafael R | CFO, Sr. VP | G - Gift | $0.00 | +34.5K | 34.5K | New | $0 |
| D | 2022-01-31 | 2021-09-08 | TXN | Lizardi Rafael R | CFO, Sr. VP | G - Gift | $0.00 | -34.5K | 47.7K | -42% | $0 |
| D | 2022-01-31 | 2022-01-27 | TXN | Lizardi Rafael R | CFO, Sr. VP | A - Grant | $0.00 | +10.9K | 58.6K | +23% | $0 |
| D | 2022-01-31 | 2022-01-27 | TXN | Lizardi Rafael R | CFO, Sr. VP | A - Grant | $0.00 | +47.7K | 47.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-31 | F | D | 3,658 | $177.29 | 54,930 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-18 | G | A | 33,994 | $0.00 | 33,994 | I | — | — | |
| 3 | Common | Common Stock | 2021-10-18 | G | D | 33,994 | $0.00 | 550 | I SLAT | — | — | |
| 4 | Common | Common Stock | 2021-09-08 | G | A | 34,544 | $0.00 | 34,544 | I By Spouse | — | — | |
| 5 | Common | Common Stock | 2021-09-08 | G | D | 34,544 | $0.00 | 47,655 | D By Spouse | — | — | |
| 6 | Common | Common Stock | 2022-01-27 | A | A | 10,869 | $0.00 | 58,588 | D | — | — | (F3) Award of restricted stock units pursuant to 2009 Long-Term Incentive Plan. |
| 7 | Derivative | NQ Stock Option (Right to Buy) | 2022-01-27 | A | A | 47,734 | $0.00 | 47,734 | D | $174.81 · — to 2032-01-27 | 47,734 Common Stock | (F4) The option becomes exercisable in four equal annual installments beginning on January 27, 2023. |